For the T2D outcome, LDL-C-lowering HMGCR and TG-lowering LPL variants had causal effects on reduced T2D risks in both FinnGen and DIAGRAM databases (Fig. 3B). Here, HMGCR is linked to type 2 diabetes mellitus.